Fixed Dose Flavonoid Isoquercetin on Thrombo-Inflammatory Biomarkers in Subjects With Stable Sickle Cell Disease
Clinical trial NCT04514510 · COMPLETED
Trial details
- NCT number
- NCT04514510
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-02
- Primary completion
- 2022-06-13
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.